NEW YORK, July 10, 2017 -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York, case no. 1:17-cv-04604, on behalf of shareholders of Patheon N.V. (“Patheon” or the “Company”) (NYSE:PTHN) who held Patheon securities and have been harmed by Patheon’s and its board of directors’ (the “Board”) alleged violations of Sections 14(e), 14(d)(4), and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and SEC Rule 14d-9 in connection with the proposed acquisition (“Proposed Transaction”) of the Company by Thermo Fisher (CN) Luxembourg S.à r.l.
On May 31, 2017, Thermo Fisher (CN) Luxembourg S.à r.l., a wholly-owned subsidiary of Thermo Fisher Scientific Inc., commenced a tender offer for Patheon shares scheduled to expire on August 10, 2017.
If you wish to obtain information concerning this action or view a copy of the complaint, you can do so by clicking here: www.faruqilaw.com/PTHNnotice.
Pursuant to the terms of the Purchase Agreement, which was unanimously approved by the Board, Patheon shareholders stand to receive $35.00 per share in cash for each share they own. The complaint claims that this offer is inadequate given Patheon’s recent financial performance and strong growth prospects and alleges that the Schedule 14D-9 Solicitation/Recommendation Statement (the “14D-9”) provides materially incomplete and misleading information concerning Patheon’s financial projections and the valuation analyses performed by the Company’s financial advisor, in violation of Sections 14(e), 14(d)(4), and 20(a) of the Exchange Act.
Take Action
Plaintiff is represented by Faruqi & Faruqi, LLP, a law firm with extensive experience in prosecuting class actions, and significant expertise in actions involving corporate fraud. Faruqi & Faruqi, LLP, was founded in 1995 and the firm maintains its principal office in New York City, with offices in Delaware, California, and Pennsylvania.
If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you wish to discuss this action, or have any questions concerning this notice or your rights or interests, please contact:
Nadeem Faruqi, Esq.
James M. Wilson, Jr., Esq.
FARUQI & FARUQI, LLP
685 3rd Avenue, 26th Floor
New York, NY 10017
Tel.: (212) 983-9330
Fax: (212) 983-9331
E-mail: [email protected]
[email protected]


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Apple Turns 50: From Garage Startup to AI Crossroads
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



